-
Showed that treatment with esketamine resulted in a statistically significant, clinically meaningful... read more
Showed that treatment with esketamine resulted in a statistically significant, clinically meaningful... read more
Alkermes today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for ALKS 5461, a novel, once-daily, oral investigational medicine... read more
AstraZeneca and Merck today presented data from the Phase 3 OlympiAD trial showing the final overall survival (OS) results for Lynparza in metastatic breast cancer. The trial compared Lynparza ... read more
Merck today announced findings from the Phase 3 EORTC1325/KEYNOTE-054 trial investigating Keytruda, Merck’s anti-PD-1 therapy, as adjuvant therapy in resected, high-risk stage III melanoma. Study... read more
DNAtix has completed the first Proof Of Concept (POC) test by transferring the complete genome sequence of a virus - Enterobacteria phage phiX174 sensu lato - over the Ethereum Blockchain. The... read more
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,